May 29, 2023
admin
Remus Pharmaceuticals IPO Particulars & Guidance at Chanakyanipothi.com,
the Oldest & the most Trusted Investment Website in India for coming up IPOs. Operational since 8th December 1999, this is the Only Investment Platform in India, which has successfully completed 23 Years.
Remus Pharmaceuticals Listing Estimate:
The IPO received strong response and also there is steady fancy in the grey market. The IPO is expected to get listed around Rs. 1800.
Actual Listing at Rs. 1711.25
Remus Pharmaceuticals IPO Review:
There is sudden rise in the turnover and profits in the year just prior to the IPO and we cannot comment whether such profits will continue in future or not. This is mainly a trading company and has no niche business. However, the IPO has fancy in the grey market and only from that angle, you may apply this IPO.
What is the GMP of Remus Pharmaceuticals IPO?GMP prior to listing
GMP Rs. 55
Allotted Application Rate Rs.50000
Remus Pharmaceuticals IPO Subscription Status
On 19 May 2023 @ 5.00 (closed)
QIB: 138750 Shares 10.75 T
NII: 41625 Shares 229.29 T
RII: 97125 Shares 49.53 T
Total: 277500 Shares 57.11 T
Remus Pharmaceuticals IPO Particulars & Guidance:
About the business
The company is engaged in the marketing and distributing of finished formulations of pharmaceutical drugs.
The product offerings of the company can be classified into two major categories:
1. APIs: Active Pharmaceutical Ingredient (API) is the biologically active component of a drug product (tablet, capsule, cream, injectable) that produces the intended effects.
2. Finished Pharmaceutical Formulations: Finished pharmaceutical formulations are therapeutic drugs available in different dosage forms.
Get more information about the company @ www.remuspharma.com
| Remus Pharmaceuticals IPO Details | |
| IPO opens on Tentative | 17 May 2023 |
| IPO closes on | 19 May 2023 |
| Issue Type | Book Built Issue IPO |
| Issue Size | 388000 Sh /Rs 47.69 Cr |
| * Fresh Issue | 388000 Sh /Rs 47.69 Cr |
| * Offer for Sale | – Sh /Rs – Cr |
| Face Value per share: | Rs. 10 |
| Price Band | Rs.1150-1229 |
| Employee discount | Rs. 0 per share |
| Retail Lot Size | 100 Shares |
| Listing will at | NSE Sme |
| Shares offered to | ||
| Shares | Rs. (Cr) | |
| QIB (50%) | 184250 | – |
| NII (15%) | 55275 | – |
| RII (35%) | 128975 | – |
| Total Shares | 368500 | 45.29 |
| Retail portion will be oversubscribed by | 1290 | |
| Forms | ||
| How much Shares to Apply in Remus Pharmaceuticals IPO? | ||
| Min Retail Application | 100 Sh | Rs. 122900 |
| Min HNI Application | 200 Sh | Rs. 245800 |
Who are the Promoters of Remus Pharmaceuticals IPO?
MR. ARPIT DEEPAKKUMAR SHAH, MS. ROMA VINODBHAI SHAH, MR. SWAPNIL JATINBHAI SHAH AND MRS. ANAR SWAPNIL SHAH
What are the Objects of Remus Pharmaceuticals IPO?
The Company proposes to utilize the Net Proceeds from the Issue
1. To Meet Working Capital Requirements
2. Funding investments for acquisitions and general corporate purposes
| IPO Tentative timetable | |
| IPO opens on | 17 May 2023 |
| IPO Closes on | 19 May 2023 |
| IPO Allotment on | 24 May 2023 |
| Unblocking of ASBA | 25 May 2023 |
| Credit of Shares | 26 May 2023 |
| Listing on | 29 May 2023 |
| Registered Office of the Company |
| 1101 to 1103, South Tower, One 42, B/H Ashok Vatika, Nr. Jayantilal Park BRTS, Ambli bopal Road, Ahmedabad -380054, Gujarat |
| Who are the Lead Managers of Remus Pharmaceuticals IPO? |
| Beeline Capital Advisors Pvt. Ltd. |
| Who is the Registrar to IPO? |
| Link Intime India Private Limited |
| IPO Financial & Analytical Ratios | ||||
| Year | Total Income | Net Profit | EPS | RoNW |
| Rs.in Cr | Rs.in Cr | Rs. | % | |
| 2019-20 | 37.61 | 0.27 | 3.49 | 6.75 |
| 2020-21 | 73.73 | 0.91 | 11.71 | 18.46 |
| 2021-22 | 119.78 | 2.05 | 26.45 | 29.43 |
| Book Value of the Share on | 31.03.2022 | Rs.149.35 | ||
| Book Value of the Share | after the IPO | Rs.- | ||
| Offer Price | Rs. 78 | |||
| Remus Pharmaceuticals Key Performance indicators |
|
| Upper Price/last EPS | ? |
| Upper price/BV Ratio | ? |
| Upper price/BV after IPO | – |
–
IPO Particulars & Guidance
Peer Comparison:
There are no listed companies in India that engage in all aspects of the business that it operates. Accordingly, it is not possible to provide an industry comparison in relation to the Company.
# This is only coverage of News related to Grey Market Premium & subject to rates. We do not deal in grey market premium. We do not recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.
>>Go to Mainboard IPOs Section: Click
>>Get Good Staff or Job, Click: Staffavailable.com
>>Interested in Used Automobiles or vintage cars? Click: BigGaddi.com
>>Get solid Guidance on Mutual fund Investments, Click: ChanakyaMFGuidance.com
>>Study Stock Research Reports, Click: AnalysisLibrary.com
>>Interested in Crossword Puzzles? Click: Magajmari.com
